In a global health landscape marked by rising needs and constrained resources, it’s never been more critical to back what works — solutions that deliver proven impact, efficiently and at scale. That’s why we’re thrilled to welcome Danielle Bayer as our new Chief Growth Officer, to help expand our impact and bring critical health solutions to the people who need them most.
Danielle brings nearly two decades of leadership in nonprofit growth, fundraising, and global development. Most recently, she served as Managing Director at Founders Pledge, where she led global membership expansion and fundraising during a period of exponential growth. There, she launched Equity for Impact, raising $1.7 billion in charitable pledges in its first year by enabling equity donations from employees at pre-IPO companies. Her track record in innovative resource mobilization will be invaluable as we grow our impact.
“I’m excited to support the world's most effective health interventions,”
says Danielle. “I'll be working alongside an incredible team to amplify our voice so more people discover Evidence Action’s life-saving work — and are inspired to support us in achieving bold goals, like helping to end preventable child deaths.”
Danielle will lead our work to engage a global community of philanthropists and institutions committed to using evidence to maximize impact per dollar.
"Too many people still lack access to simple, life-saving health solutions — not because they don’t exist, but because they’re not funded at scale. This means every day lives that could be saved aren't, and children who could thrive don't," says Kanika Bahl, CEO of Evidence Action.
"Danielle's leadership will help us connect bold philanthropic partners with interventions that deliver exceptional impact and reach."
Evidence Action has already reached over 530 million people — from mothers delivering healthy babies thanks to prenatal syphilis treatment, to children attending more days of school due to safe water and deworming medicine.
And we’re just getting started.
Our Accelerator is identifying and testing more high-potential interventions that meet our standards for cost-effectiveness, scalability, and government partnership. What stands between these solutions and the people they can help is the funding to make scale possible.
As Danielle leads the charge to grow our global community of supporters, we’re doubling down on our invitation to the world: Think big, act urgently.
We’ve shown what’s possible when evidence meets urgency. Now, with Danielle’s leadership, we’re calling on a global community to help us go further, faster – because millions are still waiting.